[SCHEDULE 13G] Kodiak Sciences Inc SEC Filing
Kodiak Sciences Inc. Schedule 13G filed by Point72-related filers reports collective beneficial ownership of 2,908,836 shares of Kodiak Sciences common stock, representing 5.5% of the class as of the close of business on August 18, 2025. The filing attributes shared voting and shared dispositive power of all reported shares to Point72 Asset Management, Point72 Capital Advisors, Inc., and Steven A. Cohen, with no sole voting or dispositive power reported. Point72 Associates holds the shares and Point72 Asset Management acts as investment manager; Point72 Capital Advisors is the general partner and Mr. Cohen controls the entities. The filers state the shares were not acquired to change or influence control of the issuer. A Joint Filing Agreement is filed as Exhibit 99.1.
Kodiak Sciences Inc. 鈥� Un modulo Schedule 13G presentato da soggetti collegati a Point72 indica una propriet脿 beneficiaria collettiva pari a 2.908.836 azioni ordinarie di Kodiak Sciences, corrispondenti al 5,5% della classe alla chiusura delle negoziazioni del 18 agosto 2025. La dichiarazione attribuisce a Point72 Asset Management, Point72 Capital Advisors, Inc. e Steven A. Cohen il potere di voto condiviso e il potere dispositvo condiviso su tutte le azioni segnalate, senza alcun potere di voto o dispositvo esclusivo. Le azioni sono detenute da Point72 Associates e Point72 Asset Management agisce come gestore degli investimenti; Point72 Capital Advisors 猫 la general partner e il signor Cohen controlla tali entit脿. I soggetti dichiarano che le azioni non sono state acquisite con l'intento di modificare o influenzare il controllo dell'emittente. Un Accordo di Deposizione Congiunta 猫 allegato come Exhibit 99.1.
Kodiak Sciences Inc. 鈥� Un Schedule 13G presentado por filiales relacionadas con Point72 informa una titularidad beneficiaria conjunta de 2.908.836 acciones ordinarias de Kodiak Sciences, que representan el 5,5% de la clase al cierre de operaciones del 18 de agosto de 2025. La presentaci贸n atribuye a Point72 Asset Management, Point72 Capital Advisors, Inc. y Steven A. Cohen el poder de voto compartido y el poder dispositvo compartido sobre todas las acciones informadas, sin detentar poder de voto o dispositvo exclusivo. Las acciones est谩n en poder de Point72 Associates y Point72 Asset Management act煤a como gestor de inversiones; Point72 Capital Advisors es la sociedad gestora general y el se帽or Cohen controla dichas entidades. Los presentantes declaran que las acciones no se adquirieron con el prop贸sito de cambiar o influir en el control del emisor. Se presenta un Acuerdo de Presentaci贸n Conjunta como Exhibit 99.1.
Kodiak Sciences Inc. 鈥� Point72 甏�霠� 瓿勳棿靷皜 鞝滌稖頃� Schedule 13G鞐� 霐半ゴ氅�, Kodiak Sciences鞚� 氤错喌欤� 2,908,836欤茧ゼ 歆戫暕鞝� 鞁れ氤挫湢頃橁碃 鞛堨溂氅� 鞚措姅 2025雲� 8鞗� 18鞚� 鞓侅梾膦呺 旮办鞙茧 鞝勳泊 韥措灅鞀れ潣 5.5%鞐� 頃措嫻頃╇媹雼�. 鞝滌稖靹滊電� 氤搓碃霅� 氇摖 欤检嫕鞐� 雽�頃� Point72 Asset Management, Point72 Capital Advisors, Inc. 氚� Steven A. Cohen鞚� 瓿惦彊 鞚橁舶甓� 氚� 瓿惦彊 觳橂秳甓�鞚� 氤挫湢頃橂┌ 雼弲 鞚橁舶甓� 霕愲姅 雼弲 觳橂秳甓岇潃 鞐嗠嫟瓿� 氚濏灆雼堧嫟. 欤检嫕鞚� Point72 Associates臧� 氤挫湢頃橁碃 Point72 Asset Management臧� 韴瀽 甏�毽瀽 鞐暊鞚� 頃橂┌, Point72 Capital Advisors電� 鞚茧皹韺岉姼雱堨澊瓿� Cohen 鞌皜 頃措嫻 氩曥澑霌れ潉 韱奠牅頃╇媹雼�. 鞝滌稖鞛愲摛鞚� 頃措嫻 欤检嫕鞚� 氚滍枆鞚胳潣 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼鞚� 氙胳箻旮� 鞙勴暣 旆摑霅� 瓴冹澊 鞎勲媹霛缄碃 氇呾嫓頄堨姷雼堧嫟. 瓿惦彊 鞝滌稖 瓿勳暯靹滊姅 Exhibit 99.1搿� 鞝滌稖霅橃柎 鞛堨姷雼堧嫟.
Kodiak Sciences Inc. 鈥� Une Schedule 13G d茅pos茅e par des entit茅s li茅es 脿 Point72 indique une propri茅t茅 b茅n茅ficiaire collective de 2 908 836 actions ordinaires de Kodiak Sciences, repr茅sentant 5,5 % de la cat茅gorie 脿 la cl么ture des op茅rations le 18 ao没t 2025. Le d茅p么t attribue 脿 Point72 Asset Management, Point72 Capital Advisors, Inc. et Steven A. Cohen le pouvoir de vote partag茅 et le pouvoir de disposition partag茅 sur toutes les actions d茅clar茅es, sans aucun pouvoir de vote ou de disposition exclusif. Les actions sont d茅tenues par Point72 Associates et Point72 Asset Management agit en tant que gestionnaire d'investissement ; Point72 Capital Advisors est le commandit茅 et M. Cohen contr么le ces entit茅s. Les d茅clarants indiquent que les actions n'ont pas 茅t茅 acquises dans le but de modifier ou d'influencer le contr么le de l'茅metteur. Un accord conjoint de d茅p么t est d茅pos茅 en tant qu'Exhibit 99.1.
Kodiak Sciences Inc. 鈥� Ein Schedule鈥�13G, eingereicht von Point72鈥憂ahen Einreichern, meldet eine gemeinschaftliche wirtschaftliche Beteiligung an 2.908.836 Stammaktien von Kodiak Sciences, was zum B枚rsenschluss am 18. August 2025 5,5% der Klasse entspricht. Die Einreichung f眉hrt Point72 Asset Management, Point72 Capital Advisors, Inc. und Steven A. Cohen gemeinsames Stimm- und Verf眉gungsrecht 眉ber alle gemeldeten Aktien zu, wobei kein ausschlie脽liches Stimm鈥� oder Verf眉gungsrecht angegeben wird. Die Aktien werden von Point72 Associates gehalten; Point72 Asset Management fungiert als Investmentmanager, Point72 Capital Advisors ist der Generalpartner und Herr Cohen kontrolliert die Gesellschaften. Die Einreicher geben an, die Aktien nicht erworben zu haben, um die Kontrolle des Emittenten zu 盲ndern oder zu beeinflussen. Eine Joint Filing Agreement ist als Exhibit 99.1 eingereicht.
- Transparent reporting of ownership percentage and exact share count (2,908,836 shares, 5.5%)
- Joint Filing Agreement filed as Exhibit 99.1 clarifying coordination among filers
- Explicit statement that the position is not held to change or influence control
- None.
Insights
TL;DR: Point72 group reports a 5.5% shared stake in KOD with shared voting and dispositive power as of 8/18/2025.
The Schedule 13G discloses a passive-ownership filing by Point72 entities and Steven A. Cohen for 2,908,836 shares (5.5%) of Kodiak Sciences common stock. Ownership is reported as shared voting and shared dispositive power, indicating control is exercised through the investment fund structure rather than individually. The filers expressly state the position is not intended to influence control. For investors, this documents a notable institutional stake without an active control intent; the filing is consistent with passive reporting under applicable rules.
TL;DR: Joint filing clarifies organizational relationships and control lines among Point72 entities and Mr. Cohen.
The filing clarifies that Point72 Associates holds the shares, Point72 Asset Management has investment and voting power as manager, Point72 Capital Advisors is the general partner, and Steven A. Cohen controls the reporting entities. The Joint Filing Agreement (Exhibit 99.1) formalizes the consolidated disclosure. The absence of sole voting or dispositive power and the certification regarding non-control intent are material governance disclosures that signal a passive ownership posture while documenting potential shared decision pathways.
Kodiak Sciences Inc. 鈥� Un modulo Schedule 13G presentato da soggetti collegati a Point72 indica una propriet脿 beneficiaria collettiva pari a 2.908.836 azioni ordinarie di Kodiak Sciences, corrispondenti al 5,5% della classe alla chiusura delle negoziazioni del 18 agosto 2025. La dichiarazione attribuisce a Point72 Asset Management, Point72 Capital Advisors, Inc. e Steven A. Cohen il potere di voto condiviso e il potere dispositvo condiviso su tutte le azioni segnalate, senza alcun potere di voto o dispositvo esclusivo. Le azioni sono detenute da Point72 Associates e Point72 Asset Management agisce come gestore degli investimenti; Point72 Capital Advisors 猫 la general partner e il signor Cohen controlla tali entit脿. I soggetti dichiarano che le azioni non sono state acquisite con l'intento di modificare o influenzare il controllo dell'emittente. Un Accordo di Deposizione Congiunta 猫 allegato come Exhibit 99.1.
Kodiak Sciences Inc. 鈥� Un Schedule 13G presentado por filiales relacionadas con Point72 informa una titularidad beneficiaria conjunta de 2.908.836 acciones ordinarias de Kodiak Sciences, que representan el 5,5% de la clase al cierre de operaciones del 18 de agosto de 2025. La presentaci贸n atribuye a Point72 Asset Management, Point72 Capital Advisors, Inc. y Steven A. Cohen el poder de voto compartido y el poder dispositvo compartido sobre todas las acciones informadas, sin detentar poder de voto o dispositvo exclusivo. Las acciones est谩n en poder de Point72 Associates y Point72 Asset Management act煤a como gestor de inversiones; Point72 Capital Advisors es la sociedad gestora general y el se帽or Cohen controla dichas entidades. Los presentantes declaran que las acciones no se adquirieron con el prop贸sito de cambiar o influir en el control del emisor. Se presenta un Acuerdo de Presentaci贸n Conjunta como Exhibit 99.1.
Kodiak Sciences Inc. 鈥� Point72 甏�霠� 瓿勳棿靷皜 鞝滌稖頃� Schedule 13G鞐� 霐半ゴ氅�, Kodiak Sciences鞚� 氤错喌欤� 2,908,836欤茧ゼ 歆戫暕鞝� 鞁れ氤挫湢頃橁碃 鞛堨溂氅� 鞚措姅 2025雲� 8鞗� 18鞚� 鞓侅梾膦呺 旮办鞙茧 鞝勳泊 韥措灅鞀れ潣 5.5%鞐� 頃措嫻頃╇媹雼�. 鞝滌稖靹滊電� 氤搓碃霅� 氇摖 欤检嫕鞐� 雽�頃� Point72 Asset Management, Point72 Capital Advisors, Inc. 氚� Steven A. Cohen鞚� 瓿惦彊 鞚橁舶甓� 氚� 瓿惦彊 觳橂秳甓�鞚� 氤挫湢頃橂┌ 雼弲 鞚橁舶甓� 霕愲姅 雼弲 觳橂秳甓岇潃 鞐嗠嫟瓿� 氚濏灆雼堧嫟. 欤检嫕鞚� Point72 Associates臧� 氤挫湢頃橁碃 Point72 Asset Management臧� 韴瀽 甏�毽瀽 鞐暊鞚� 頃橂┌, Point72 Capital Advisors電� 鞚茧皹韺岉姼雱堨澊瓿� Cohen 鞌皜 頃措嫻 氩曥澑霌れ潉 韱奠牅頃╇媹雼�. 鞝滌稖鞛愲摛鞚� 頃措嫻 欤检嫕鞚� 氚滍枆鞚胳潣 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼鞚� 氙胳箻旮� 鞙勴暣 旆摑霅� 瓴冹澊 鞎勲媹霛缄碃 氇呾嫓頄堨姷雼堧嫟. 瓿惦彊 鞝滌稖 瓿勳暯靹滊姅 Exhibit 99.1搿� 鞝滌稖霅橃柎 鞛堨姷雼堧嫟.
Kodiak Sciences Inc. 鈥� Une Schedule 13G d茅pos茅e par des entit茅s li茅es 脿 Point72 indique une propri茅t茅 b茅n茅ficiaire collective de 2 908 836 actions ordinaires de Kodiak Sciences, repr茅sentant 5,5 % de la cat茅gorie 脿 la cl么ture des op茅rations le 18 ao没t 2025. Le d茅p么t attribue 脿 Point72 Asset Management, Point72 Capital Advisors, Inc. et Steven A. Cohen le pouvoir de vote partag茅 et le pouvoir de disposition partag茅 sur toutes les actions d茅clar茅es, sans aucun pouvoir de vote ou de disposition exclusif. Les actions sont d茅tenues par Point72 Associates et Point72 Asset Management agit en tant que gestionnaire d'investissement ; Point72 Capital Advisors est le commandit茅 et M. Cohen contr么le ces entit茅s. Les d茅clarants indiquent que les actions n'ont pas 茅t茅 acquises dans le but de modifier ou d'influencer le contr么le de l'茅metteur. Un accord conjoint de d茅p么t est d茅pos茅 en tant qu'Exhibit 99.1.
Kodiak Sciences Inc. 鈥� Ein Schedule鈥�13G, eingereicht von Point72鈥憂ahen Einreichern, meldet eine gemeinschaftliche wirtschaftliche Beteiligung an 2.908.836 Stammaktien von Kodiak Sciences, was zum B枚rsenschluss am 18. August 2025 5,5% der Klasse entspricht. Die Einreichung f眉hrt Point72 Asset Management, Point72 Capital Advisors, Inc. und Steven A. Cohen gemeinsames Stimm- und Verf眉gungsrecht 眉ber alle gemeldeten Aktien zu, wobei kein ausschlie脽liches Stimm鈥� oder Verf眉gungsrecht angegeben wird. Die Aktien werden von Point72 Associates gehalten; Point72 Asset Management fungiert als Investmentmanager, Point72 Capital Advisors ist der Generalpartner und Herr Cohen kontrolliert die Gesellschaften. Die Einreicher geben an, die Aktien nicht erworben zu haben, um die Kontrolle des Emittenten zu 盲ndern oder zu beeinflussen. Eine Joint Filing Agreement ist als Exhibit 99.1 eingereicht.
FAQ
How many Kodiak Sciences (KOD) shares does Point72 report owning?
Does Point72 have sole voting or dispositive power over the KOD shares?
What entities are involved in the Schedule 13G filing for KOD?
As of what date is the ownership reported?
Did the filers state an intent to influence control of Kodiak Sciences?
